Company
Surge Care
Each patient’s immune signature, decrypted
Also known as Surge, SurgeCare
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Paris, France
- Founded
- 2021
- Employees
- 15Source (opens in a new tab)
- Customers
- surgical teams
- Legal name
- SurgeCare
Claim, correct or request removal
Record updated 17 September 2026
About
PreCyte, our flagship product, is designed to measure a patient's immune response from a single blood draw to give surgical teams an objective infection risk score on day one after surgery.
Funding snapshot
- Latest round
- Undisclosed2024-03-27
Funding rounds
- Round, 2024
- 2024-03-27
Products
- Other
- PreCyte
Loading relationship preview